Presence and Significant Determinants of Cognitive Impairment in a Large Sample of Patients with Multiple Sclerosis

被引:47
|
作者
Borghi, Martina [1 ]
Cavallo, Marco [1 ,2 ]
Carletto, Sara [1 ]
Ostacoli, Luca [1 ]
Zuffranieri, Marco [1 ]
Picci, Rocco Luigi [1 ]
Scavelli, Francesco [1 ]
Johnston, Harriet [3 ]
Furlan, Pier Maria [1 ]
Bertolotto, Antonio [4 ]
Malucchi, Simona [4 ]
机构
[1] Univ Turin, Dept Mental Hlth, San Luigi Gonzaga Hosp, Sch Med,ASL TO3, Orbassano, Italy
[2] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Novara, Italy
[3] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland
[4] San Luigi Gonzaga Hosp, Sch Med, Neurol CRESM Reg Reference Ctr Multiple Sclerosis, Orbassano, Italy
来源
PLOS ONE | 2013年 / 8卷 / 07期
关键词
BRIEF REPEATABLE BATTERY; SCALE; SPEED; POPULATION; RELEVANCE; DEFICITS; MEMORY; MS;
D O I
10.1371/journal.pone.0069820
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives: To investigate the presence and the nature of cognitive impairment in a large sample of patients with Multiple Sclerosis (MS), and to identify clinical and demographic determinants of cognitive impairment in MS. Methods: 303 patients with MS and 279 healthy controls were administered the Brief Repeatable Battery of Neuropsychological tests (BRB-N); measures of pre-morbid verbal competence and neuropsychiatric measures were also administered. Results: Patients and healthy controls were matched for age, gender, education and pre-morbid verbal Intelligence Quotient. Patients presenting with cognitive impairment were 108/303 (35.6%). In the overall group of participants, the significant predictors of the most sensitive BRB-N scores were: presence of MS, age, education, and Vocabulary. The significant predictors when considering MS patients only were: course of MS, age, education, vocabulary, and depression. Using logistic regression analyses, significant determinants of the presence of cognitive impairment in relapsing-remitting MS patients were: duration of illness (OR = 1.053, 95% CI = 1.010-1.097, p = 0.015), Expanded Disability Status Scale score (OR = 1.247, 95% CI = 1.024-1.517, p = 0.028), and vocabulary (OR = 0.960, 95% CI = 0.936-0.984, p = 0.001), while in the smaller group of progressive MS patients these predictors did not play a significant role in determining the cognitive outcome. Conclusions: Our results corroborate the evidence about the presence and the nature of cognitive impairment in a large sample of patients with MS. Furthermore, our findings identify significant clinical and demographic determinants of cognitive impairment in a large sample of MS patients for the first time. Implications for further research and clinical practice were discussed.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Device-Measured Physical Activity and Cognitive Processing Speed Impairment in a Large Sample of Persons with Multiple Sclerosis
    Sandroff, Brian M.
    Motl, Robert W.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2020, 26 (08) : 798 - 805
  • [32] Disease activity is a significant factor of cognitive impairment in patients with relapsing-remitting multiple sclerosis and low disability
    Pizzolato, G
    Benedetti, MD
    Freo, U
    Moretto, G
    Colledan, L
    Fiumani, A
    Gigli, G
    Lucci, B
    Ravenna, C
    Rizzuto, N
    Tezzon, F
    Toso, V
    Battistin, L
    ANNALS OF NEUROLOGY, 2002, 52 (03) : S40 - S41
  • [33] Cognitive impairment in relapsing- remitting multiple sclerosis patients
    Altinkaya, A.
    Ozcan, E.
    Kuscu, D.
    Kurt, E.
    Bingol, A.
    Kirbas, D.
    Topcular, B.
    JOURNAL OF NEUROLOGY, 2013, 260 : S132 - S132
  • [34] Global activation as a measure of cognitive impairment in patients with Multiple Sclerosis
    Gross, M
    Rotte, M
    Sailer, M
    Heinze, HJ
    Münte, T
    NEUROIMAGE, 2001, 13 (06) : S795 - S795
  • [35] Effect of Boswellia serrata on cognitive impairment in multiple sclerosis patients
    Majdinasab, Nastaran
    Siahpush, Amir
    Mousavinejad, Seyedeh Khatoon
    Malayeri, Alireza
    Sajedi, Seyed Aidin
    Bizhanzadeh, Parisa
    JOURNAL OF HERBAL MEDICINE, 2016, 6 (03) : 119 - 127
  • [36] The impact of cognitive impairment on the quality of life in patients with multiple sclerosis
    Kostic, J.
    Drulovic, J.
    Stojsavljevic, N.
    Tepavcevic, D. Kisic
    Pekmezovic, T.
    Mesaros, S.
    Basuroski, I. Dujmovic
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S226 - S227
  • [37] Cerebellar dysfunction is associated with cognitive impairment in patients with multiple sclerosis
    Skibina, O.
    Butzkueven, H.
    MacGregor, L.
    Velakoulis, D.
    Holmes, A.
    Spain, L.
    Adams, S.
    Kilpatrick, T.
    MULTIPLE SCLEROSIS, 2006, 12 : S33 - S34
  • [38] The Usefulness of Saccades in the Diagnosis of Cognitive Impairment in Multiple Sclerosis Patients
    Ksciuk, B.
    Matusik, E.
    Rudzinska-Bar, M.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 68 - 68
  • [39] Associations Between Cognitive Impairment and Neuroimaging in Patients with Multiple Sclerosis
    Wilcox, Olivia
    Amin, Moein
    Hancock, Laura
    Nakamura, Kunio
    Lace, John
    Ontaneda, Daniel
    Galioto, Rachel
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2024, 39 (02) : 196 - 203
  • [40] Is there a correlation between dyslipidemia and cognitive impairment in patients with multiple sclerosis?
    Andaloro, Adriana
    Russo, Margherita
    Pastura, Concetta
    Sessa, Edoardo
    Calatozzo, Patrizia
    Maggio, Maria Grazia
    Bramanti, Placido
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2021, 132 (02) : 201 - 206